Dr. Snejana Krassova Bayer, Switzerland

Dr. Snejana Krassova has nearly 20 years of experience in medical affairs and clinical development in hematology and rare bleeding disorders. She has a strong background in education and research as a medical professional and holds a Master of Medical Management and Business Strategy (Copenhagen Business School).... read more

Taking her role at Bayer in March 2017, Snejana previously held senior positions in a variety of pharmaceutical companies including Novo Nordisk and Biogen Idec.

Her extensive experience in Global Medical Affairs and Clinical Development roles has involved being responsible for all pipeline products and life cycle management of marketed agents.

Snejana has also been responsible for scientific aspects in preparation, execution and follow-up of global studies, medical events/education programmes/activities and she was responsible for and supported submission processes. In previous roles Snejana has also been responsible for training on medical aspects in immunology and hematology. She has published in peer-reviewed journals and is an active member of the American Society of Hematology and International Society of Thrombosis and Haemostasis.